CN
212-133-3
应用筛选条件
关键词:'212-133-3'
显示 1-30 共 32 条结果 关于 "212-133-3" 范围 技术文档
Data Sheet - I0157
Res.,
837, 203-212 (1999).
5. Takuma, K., et al., Ibudilast attenuates astrocyte
apoptosis via cyclic GMP signaling pathway in an in
vitro reperfusion model. Br. J. Pharmacol., 133,
841-848 (2001
Data Sheet - 07298
antibodies using IdeS proteolytic
digestion and electrospray mass spectrometry.
Anal. Biochem., 415, 212-214 (2011).
11. Lišková, M., et al., Conjugation reactions in the
preparations of quantum dot-based
Data Sheet - 77661
antibodies using IdeS proteolytic
digestion and electrospray mass spectrometry.
Anal. Biochem., 415, 212-214 (2011).
11. Lišková, M., et al., Conjugation reactions in the
preparations of quantum dot-based
Product Information Sheet - CS0270
vial 100,000 ng/mL
1 966 µL 34 µL (0) 3,400
2 500 µL 500 µL 1,700
3 500 µL 500 µL 850
4 500 µL 500 µL 425
5 500 µL 500 µL 212
6 500 µL 500 µL 106
MultiScreen Filter Plates with Ultracel®-10 Membrane
55 43 33 33 43 54 61
30 ABS 68 57 45 37 37 47 60 68
BSA 199 220 217 212 200 205 192 185
Buffer 208 235 226 228 227 223 212 193
Cyto c 199 237 226
Quality Control Range Sheet- B6062-101A and B6062-201A
Control 2 314 – 653 pg/mL
CXCL16 Control 1 189 – 393 pg/mL IL-11 Control 1 102 – 212 pg/mL
Control 2 652 – 1355
Examination of Non-Specifically Bound Proteins and Peptides Following Depletion of Twenty High Abundance Proteins from Human Plasma
protein 83 1 163 3 207 4 212 5 133 3 259 4 206 3 319 6
IPI00550640 IGHG4 protein 275 4 111 2 338 3 82 2 337 6 86 2 391 4 193 4 270 4 329
XP725 Antibody Number-Lot Number 071M4826
273 274 275 276
3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284
3.6 213 214 215 216
Product Information - CSAA1
Transduction P
y y n/d
197 Cdc7 Kinase C6613 Signal Transduction M y n/d n/d
198 PAK phospho (pS
212) Clone:PK-18 P3237 Signal Transduction M y y y
199 Phospholipase A2 group V P5242 Signal
PKH Dye Reference Guide
resistance 2, 3, 74, 163
Differentiation 1, 11, 33, 70, 80, 107, 137
Proliferation 1-3, 16, 18, 30, 36, 58, 62, 78, 91-93, 124, 125, 133
Conjugate formation, adhesion,
and/or fusion
Stem Cell and Specialty Cell Culture Product Guide
....................133
16-201 .......................................133
16-661 .......................................133
16-661X .....................................133
17-229 ..........
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
the SAPK2/3, or p38 family of stress-activated kinases. MAPKAP Kinase 2 and 3 phosphorylate
substrates with the sequence H-X-R-X-X-S where H is any hydrophobic residue, including CREB (Ser 133) and HSP27
SMC Plate-based Immunoassay Development Kit (5 plates)
# 2 140 4 227 39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307 48
# 6 186 3 304 54
Protocol- 03-0179-00
# 2 140 4 227 39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307 48
# 6 186 3 304 54
Protocol- 03-0178-00
39
# 3 131 4 210 30
# 4 133 3 216 41
# 5 188 4 307 48
# 6 186 3 304 54
# 7 209 3 343 62
# 8 183 4 298 46
# 9 195
EZ-Magna ChIP™ HT96 (Cat. No. 17-10078)
nr
ic
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
Magna ChIP™ HT96
nr
ic
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
Magna ChIP™ HT96 (Cat. No. 17-10077)
nr
ic
hm
en
t
Antibody Performance Using
Magna ChIP HT96 Panel II
1 84 108
133 212
627
1219
1935
0
500
1000
1500
2000
2500
XP725 Antibody List Lot 129K4831
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
XP725 Antibody List Lot 129K4830
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
XP725 Antibody List Lot 089K4791
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
Apoptosis - Antibodies, Reagents and Kits
$319
Anti-PI 3-Kinase, p85, N-SH3, clone AB6 H M WB IP IC M IgG1κ 100 µg 05-212 $339
Anti-PI 3-Kinase, p85, N-SH2, clone UB93-3 H M R WB IP M IgG 200 µL 05-217 $329
List of Antibodies
y n/d y
210 Cytokeratin peptide 18 C1399 M y n/d n/d
211 Cytokeratin peptide 19 C6930 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 M y n/d
3D BIOPRINTING: Printing a Brighter Future
behaviors such as these may soon become widespread in
tissue engineering and tissue model engineering.210–212
Physical Properties
Several physical properties must be considered for the clinical
translation
3D BIOPRINTING: Printing a Brighter Future
behaviors such as these may soon become widespread in
tissue engineering and tissue model engineering.210–212
Physical Properties
Several physical properties must be considered for the clinical
translation
XP725 Antibody List
http://www.sigmaaldrich.com/ProductLookup.html?ProdNo=G7670&Brand=SIGMA�
3 9
3 9
3 9
3 9
3 9
3 9
3 9
T 3
3 9
3 9
334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n
Halal Certificate
W341509 A16595 HC-23SI9Z56
210. 3-(METHYLTHIO)BUTANAL 96%, FG W337404 B35350 HC-23SIGN93
211. 3-(METHYLTHIO)HEXYL ACETATE 97%, FG W378917 B23379 HC-23SI1J13
212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE
Halal Certificate
W341509 A16595 HC-22SIJM77
210. 3-(METHYLTHIO)BUTANAL 96%, FG W337404 B35350 HC-22SIF215
211. 3-(METHYLTHIO)HEXYL ACETATE 97%, FG W378917 B23379 HC-22SI7U34
212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE
XP725 Worksheet for Lot Number 071M4826
127 1 3 4 7 Seladin S4697
128 1 3 4 8 Seladin S4697
129 1 3 5 1 Bcl2 B9804
130 1 3 5 2 Bcl2 B9804
131 1 3 5 3 Bcl2 B3170
132 1 3 5 4 Bcl2 B3170
133 1 3 5
XP725 Antibody List 013M4793
KRT18 NP_954657.1 M y n/d n/d
211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y
1/2